Related references
Note: Only part of the references are listed.被撤回的出版物: Effects of green synthesised silver nanoparticles (ST06-AgNPs) using curcumin derivative (ST06) on human cervical cancer cells (HeLa) in vitro and EAC tumor bearing mice models (Retracted article. See vol. 17, pg. 3077, 2022)
Kalaimathi Murugesan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Treatment Effect of Tuftsin and Antigen Peptide Combined with Immune Cells on Colorectal Cancer
Boyuan Zou et al.
MEDICAL SCIENCE MONITOR (2019)
Comparative Effect Of Curcumin Versus Liposomal Curcumin On Systemic Pro-Inflammatory Cytokines Profile, MCP-1 And RANTES In Experimental Diabetes Mellitus
Adriana Elena Bulboaca et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Toxicity of Doxorubicin (Dox) to different experimental organ systems
Arivalagan Pugazhendhi et al.
LIFE SCIENCES (2018)
Tuftsin - Properties and Analogs
Agnieszka Siebert et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Targeted nano-delivery of novel omega-3 conjugate against hepatocellular carcinoma: Regulating COX-2/bcl-2 expression in an animal model
Azmat Ali Khan et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging
Micah D. K. Glasgow et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2015)
Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complex
Naoshad Mohammad et al.
SCIENTIFIC REPORTS (2015)
Advances and Challenges of Liposome Assisted Drug Delivery
Lisa Sercombe et al.
FRONTIERS IN PHARMACOLOGY (2015)
Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculature
Sugata Barui et al.
BIOMATERIALS (2014)
Tuftsin signals through its receptor neuropilin-1 via the transforming growth factor beta pathway
Jillian C. Nissen et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery
Tianyue Jiang et al.
BIOMATERIALS (2012)
Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles
Jinghua Duan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy
Dipankar Pramanik et al.
ONCOTARGET (2012)
Coformulation of Doxorubicin and Curcumin in Poly(D,L-lactide-co-glycolide) Nanoparticles Suppresses the Development of Multidrug Resistance in K562 Cells
Ranjita Misra et al.
MOLECULAR PHARMACEUTICS (2011)
Coadministration of Paclitaxel and Curcumin in Nanoemulsion Formulations To Overcome Multidrug Resistance in Tumor Cells
Srinivas Ganta et al.
MOLECULAR PHARMACEUTICS (2009)
Tuftsin augments antitumor efficacy of liposomized etoposide against fibrosarcoma in swiss albino mice
Arif Khan et al.
MOLECULAR MEDICINE (2007)
Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin
Pornngarm Limtrakul et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2007)
Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy
Fabio Pastorino et al.
CANCER RESEARCH (2006)
Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model
Masood A. Khan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1)
W Chearwae et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
S Sengupta et al.
NATURE (2005)
In vivo reversal of doxorubicin resistance by (-)-epigallocatechin gallate in a solid human carcinoma xenograft
Q Zhang et al.
CANCER LETTERS (2004)
Defects in the apoptotic machinery of cancer cells: role in drug resistance
B Zhivotovsky et al.
SEMINARS IN CANCER BIOLOGY (2003)
Apoptosis-regulating proteins as targets for drug discovery
JC Reed
TRENDS IN MOLECULAR MEDICINE (2001)
Regulation and function of the p53 tumor suppressor protein
KM Ryan et al.
CURRENT OPINION IN CELL BIOLOGY (2001)
Tuftsin-bearing liposomes in treatment of macrophage-based infections
AK Agrawal et al.
ADVANCED DRUG DELIVERY REVIEWS (2000)
Share Paper
